So far, 25 representatives of the U.S. FDA are confirmed to speak at the 2017 PDA/FDA Joint Regulatory Conference.
CBER Director Peter Marks, MD, PhD, will launch the meeting by offering an FDA perspective on innovation for medical products in
the opening plenary, Sept. 11 at 8:30 a.m. Confirmed FDA speakers consist of the following:
- Carmelo Rosa, CDER
- Brooke K. Higgins, CDER
- Deborah A. Hursh, PhD, CBER
- James Coburn, CDRH
- Linda J. Ricci, CDRH
- Debra Y. Lewis, Office of Orphan
Products Development
- Patricia Y. Love, MD, Office of
Combination Products
- Amy E. McKee, MD, Oncology CoE
- Francis Godwin, CDER
- Robert D. McElwain, CBER
- Paula Katz, CDER
- Theresa M. Mullin, PhD, CDER
- Joan W. Blair, CBER
- Shannon M. Hoste, CDRH
- Tamara L. Ely, CDER
- Christopher Joneckis, PhD, CBER
- Robin Newman, CDRH
- Steven Solomon, CVM
- Douglas Throckmorton, MD, CDER
- Donald Ashley, CDER
- Sean Boyd, CDRH
- Martine Hartogensis, CVM
- Mary Marlarkey, CBER
- Douglas Stearn, ORA
Continue to check the website for the meeting as new speakers are added to the agenda.